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Abstract
OBJECTIVES: This study investigated whether the novel St. Thomas’ Hospital polarizing cardioplegic solution (STH-POL) with esmolol/ad-
enosine/magnesium offers improved myocardial protection by reducing demands for high-energy phosphates during cardiac arrest com-
pared to the depolarizing St. Thomas’ Hospital cardioplegic solution No 2 (STH-2).
METHODS: Twenty anaesthetised pigs on tepid cardiopulmonary bypass were randomized to cardiac arrest for 60 min with antegrade
freshly mixed, repeated, cold, oxygenated STH-POL or STH-2 blood cardioplegia every 20 min. Haemodynamic variables were continu-
ously recorded. Left ventricular biopsies, snap-frozen in liquid nitrogen or fixed in glutaraldehyde, were obtained at Baseline, 58 min after
cross-clamp and 20 and 180 min after weaning from bypass. Adenine nucleotides were evaluated by high-performance liquid chromatog-
raphy, myocardial ultrastructure with morphometry.
RESULTS: With STH-POL myocardial creatine phosphate was increased compared to STH-2 at 58 min of cross-clamp [59.9 ± 6.4 (SEM) vs
44.5 ± 7.4 nmol/mg protein; P < 0.025], and at 20 min after reperfusion (61.0 ± 6.7 vs 49.0 ± 5.5 nmol/mg protein; P < 0.05), ATP levels were
increased at 20 min of reperfusion with STH-POL (35.4 ± 1.1 vs 32.4 ± 1.2 nmol/mg protein; P < 0.05). Mitochondrial surface-to-volume
ratio was decreased with polarizing compared to depolarizing cardioplegia 20 min after reperfusion (6.74 ± 0.14 vs 7.46 ± 0.13mm2/mm3;
P = 0.047). None of these differences were present at 180 min of reperfusion. From 150 min of reperfusion and onwards, cardiac index was
increased with STH-POL; 4.8 ± 0.2 compared to 4.0 ± 0.2 l/min/m2 (P = 0.011) for STH-2 at 180 min.
CONCLUSIONS: Polarizing STH-POL cardioplegia improved energy status compared to standard STH-2 depolarizing blood cardioplegia
during cardioplegic arrest and early after reperfusion.
Keywords: Cardioplegia • Myocardial protection • Energy metabolism • Ultrastructure
INTRODUCTION
Repeated hyperkalaemic blood cardioplegia, considered by many
to provide optimal myocardial protection, induces depolarization
and re-equilibration of the resting cell membrane potential. This
inactivates the voltage-dependent fast Na+ channels [1], prevents
initiation of the action potential and induces depolarized diastolic
arrest. However, this will cause intracellular Na+ and Ca2+ overload
by activation of the Na+/H+-exchanger and reversal of the Na+/
Ca2 + exchanger; the resulting imbalance in cytosolic ion compos-
ition activates energy utilizing compensatory mechanisms [2].
By inducing ‘polarized’ (non-depolarized) arrest the myocyte
membrane potential is maintained at or near the resting mem-
brane potential [3]. In isolated hearts, polarized cardiac arrest re-
duces myocardial oxygen consumption compared to depolarized
arrest, probably as a result of reduced activation of energy-
dependent cellular ion channels/pumps, and hence further
reduced needs for high-energy phosphates (HEP) during cardiac
arrest [4]. The normokalaemic St. Thomas’ Hospital polarizing car-
dioplegic solution (STH-POL) with esmolol/adenosine/magnesium
avoids depolarized arrest and reduces the potassium load. A re-
cent experimental study demonstrated comparable myocardial
protection and improved postoperative contractility with STH-POL
cardioplegia compared to St. Thomas’ Hospital cardioplegic
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solution No 2 (STH-2) [5]. In the present study, using the same
clinically relevant porcine model, we investigated whether cardio-
plegic arrest with STH-POL offers myocardial protection compar-
able to a standard depolarizing potassium-based cardioplegic
solution (STH-2), with the main focus on tissue levels of HEP and
myocardial ultrastructure during aortic clamping and early and
late after weaning from cardiopulmonary bypass (CPB).
METHODS
Anaesthesia and instrumentation
The experiments were conducted in accordance with the
European Communities Council Directive of 2010 (63/EU) and
approved by the Norwegian State Commission for Laboratory
Animals (Project 20135835). Twenty-two pigs (Norwegian land
race) of either gender, weighing 42 ± 3 (SD) kg were premedi-
cated with an i.m. injection of ketamine, diazepam and atropine.
Spontaneous ventilation on mask with oxygen and 3% isoflurane
(Rhodia, Bristol, UK) allowed intravenous access through two ear
veins. Loading doses followed by continuous infusions of fen-
tanyl, midazolam, pentobarbital and pancuronium secured gen-
eral anaesthesia and analgesia. This anaesthetic protocol has
previously been described and thoroughly evaluated allowing the
safe use of neuromuscular blocking agents in young pigs [5, 6].
The animals were tracheotomized, intubated and ventilated
(Julian, Dr€agerwerk, Lübeck, Germany) with nitrous oxide
(56–58%) and oxygen. Fluid substitution was Ringers acetate
(15 ml/kg/h) with added KCl (20 mmol/l) to maintain normal
plasma potassium levels after overnight fasting. In addition,
Ringers acetate 5 ml/kg/h was provided after weaning from CPB.
The right femoral artery and vein were cannulated for blood
sampling and infusion. An arterial blood gas analysis determined
the need for ventilator adjustments (ABL80 FLEX COOX,
Radiometer Medical ApS, Brønshøj, Denmark). A surgically in-
serted catheter measured diuresis and rectal temperature was
monitored. A midline sternotomy and pericardiotomy exposed
the heart and heparin (125 IU/kg) was given i.v. to prevent cath-
eter clotting. A continuous cardiac output catheter (CCO/EDV
177HF 75, Edwards Lifesciences Inc., Irvine, CA) was floated into
the pulmonary artery via the left internal mammary vein. Cardiac
output, right ventricular end-diastolic volume, central venous pres-
sure (CVP) and pulmonary artery pressure (PAP) (Vigilance IIVR and
TruWaveV
R
transducers, Edwards Lifescience Inc.) were monitored.
The proximal aorta was cannulated with a Millar microtip pressure
catheter (Millar MPC-500, Houston, TX, USA) through the left in-
ternal mammary artery. An identical catheter through the apex of
the heart monitored left ventricular pressure. The haemodynamic
parameters were recorded by a 16-channel Ponemah (ACQ-7700;
Data Sciences International, St. Paul, MN, USA).
Cardiopulmonary bypass and cardioplegia
The heart–lung machine (Stöckert SIII, Munich, Germany) was
primed with 1200 ml Ringers acetate. Heparin 500 IU/kg i.v. was
given before the brachiocephalic artery (EOPA 18 Fr, Medtronic
Inc., Minneapolis, MN, USA) and right atrial appendage (MC2 28/
36 Fr, Medtronic Inc.) were cannulated and CPB established with
a flow of 90 ml/min per kg and water temperature of 32C in the
heat exchanger. Aortic cross-clamp time was 60 min and a vent
catheter (DLP 13, Medtronic Inc.) temporarily placed through the
apex for left ventricular drainage. The body temperature was
allowed to drift and CPB flow was reduced to 72 ml/min per kg
when rectal temperature reached 35C or after 20 min. After
40 min of cross-clamping, rewarming was initiated with reset of
CPB-flow to 90 ml/min per kg and water temperature at 40C.
Arterial blood gases were obtained before aortic cross-clamping
and just before declamping after 60 min. Defibrillation of ven-
tricular fibrillation was the only allowed antiarrhythmic interven-
tion. After 10 min of reperfusion the animals were weaned from
CPB and decannulated. The residual blood in the circuit was re-
turned and protamine sulphate 1.5 mg/kg was given.
Cardioplegia was given as either the hyperkalaemic St. Thomas’
Hospital cardioplegic solution 2 (STH-2), or the normokalaemic
St. Thomas’ Hospital polarizing solution (STH-POL). Both solutions
were pre-prepared as concentrate and administered as cold
(12C), oxygenated, blood cardioplegia, freshly mixed by a dual-
head pump and separate cooling. The cardioplegia was delivered
into the aortic root with a flow set to 7% of CPB-flow, following a
standardized protocol with an initial ‘high-dose’ (1:4 concentrate/
blood) for 3 min and 2 min of ‘low-dose’ (1:8 concentrate/blood)
given at 20 and 40 min after cross-clamping. The final concentra-
tions of key components in the cardioplegic solutions are pre-
sented in the Supplementary Material, Table A.
Experimental protocol
The animals were block-randomized to the STH-POL or STH-2
group (10 per group). After 10 min of stabilization Baseline arter-
ial blood gases and haemodynamic variables were recorded. Two
myocardial biopsies from the anterior left ventricular wall were
obtained by using 6 and 4 mm biopsy punch (Integra Miltex,
York, PA, USA). Both samples included tissue from the epi- and
midmyocardium; the 6-mm biopsy was snap-frozen in liquid ni-
trogen within 5 s and stored at -80C for later analysis while the
4-mm biopsy was cut and fixed directly in glutaraldehyde.
During CPB the ventilator volume was reduced to 50% and with
passive drainage of the left ventricle. Additional heparin (250 IU/
kg) was given at 30 min of cross-clamping. After 58 min of cardio-
plegic arrest, myocardial biopsies were obtained and 2 min later
the aortic clamp was removed. The animals were weaned from
CPB after 10 min of myocardial reperfusion and decannulated.
Twenty and 180 min after declamping myocardial biopsies were
taken similar to the Baseline situation. General haemodynamics
were recorded every 15 min, from 30 to 180 min after declamping.
Finally, the animal was euthanized with intracardiac injection of
high dose potassium chloride, the heart removed and samples ob-
tained for complimentary analysis.
Myocardial metabolism and ultrastructure
High energy phosphates [ATP, ADP, AMP and creatine phosphate
(CrP)], hypoxanthine and xanthine were measured by high-
performance liquid chromatography analysis as previously
described [7]. Energy charge (EC) was calculated as:
EC ¼ [ATP] + 0:5 * [ADP]
[ATP] + [ADP] + [AMP]
Myocardial volume fraction of mitochondria, myofibrils and
cytosol were quantified by point counting in 6 randomly selected
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to volume ratio and surface density were calculated by using a
Merz grid and the freeware ImageJ [8]. To evaluate inter- and
intra-observer variability, the 6 micrographs from 15 randomly
selected biopsies were recorded and analysed individually by
two observers and by one of the observers twice. For details see
Supplementary Material.
Statistical analysis
Data were analysed using SPSS v. 23 (IBM Corp., Armonk, NY,
USA) and values given as mean ± SEM or median (25% percentile;
75% percentile) unless otherwise noted. At Baseline groups were
compared by two-sample Student t-test on data with normal dis-
tribution and with Wilcoxon–Mann–Whitney test on ranks when-
ever appropriate. Tissue contents of HEPs, degradation products
and haemodynamic variables after aortic declamping were com-
pared with two-way ANOVA for repeated measurements (RM-
ANOVA) with treatment as group factor (Pg), time as within factor
(Pw) and Pi for interaction between time and group.
Morphological variables were analysed with nested RM-ANOVA.
P < 0.05 was considered statistically significant. The intraclass cor-
relation coefficient (ICC) and coefficient of variation (CV%) for
inter- and intra-observer variability were calculated for morpho-
metric data. For details see Supplementary Material.
RESULTS
Two animals were excluded. After declamping, one animal in the
STH-POL group with profound bleeding and ventricular fibrilla-
tion prior to cross-clamp developed severe left heart failure, one
animal in the STH-2 group developed severe pulmonary hyper-
tension and right heart failure. Excluded animals were replaced
by consecutive experiments. Results are given for 10 animals in
each group, except for morphometry where the biopsies from
one STH-2 animal were lost. Haemodynamic variables, left ven-
tricular function and arterial blood gases did not differ between
groups at Baseline (Fig. 1A–F and Table 1). After 58 min of cardio-
plegic arrest, the level of serum potassium was significantly
increased in the STH-2 compared to the STH-POL group
(5.2 ± 0.3 vs 4.1 ± 0.1 mmol/l, P < 0.001). During CPB there were
no other differences between groups regarding mean arterial
pressure, temperatures and arterial blood gases (Supplementary
Material, Table B).
Cardiac and haemodynamic variables after
weaning
Heart rate increased over time in both groups after weaning
(Fig. 1A). In both groups, cardiac index (CI) was initially increased
from Baseline but subsequently decreased to a plateau level by
90 min; there were no differences between groups during this
period. At 150, 165 and 180 min after declamping, CI was
increased in the STH-POL compared to the STH-2 group
(P = 0.036, P = 0.026 and P = 0.011, respectively) (Fig. 1B). Left ven-
tricular systolic pressure was unchanged and left ventricular end-
diastolic pressure decreased gradually after declamping in both
groups (Fig. 1C and D). The first derivative of the left ventricular
pressure, LV-dP/dtmax, did not change significantly over time (Fig.
1E). LV-dP/dtmin was less negative in the STH-POL group after
30 min (P = 0.006) and 45 min (P = 0.048) of reperfusion
compared to corresponding values in the STH-2 group (Fig. 1F).
Right ventricular indexed end-diastolic volume (RV-EDVi) and
ejection fraction (RV-EF) did not change over time (Table 2).
Indexed stroke volume (RV-SVi) decreased from 60 to 120 min of
reperfusion (P < 0.001) for both groups. Central venous pressure
(CVP) gradually increased over time (Pw = 0.030) in both groups.
There were no significant differences between groups regarding
mean arterial pressure and pulmonary arterial pressure.
Myocardial high-energy phosphates
At Baseline there were no significant differences between groups
for myocardial CrP, adenine nucleotides and the degradation
products hypoxanthine and xanthine (Fig. 2A–F). CrP was signifi-
cantly increased in hearts arrested with STH-POL compared to
STH-2 after 58 min of cardiac arrest (59.9 ± 6.4 vs 44.5 ± 7.4 nmol/
mg protein; P < 0.025) and after 20 min of reperfusion (61.0 ± 6.7
vs 49.0 ± 5.5 nmol/mg protein; P < 0.05). However, at 180 min
after declamping, the CrP content did not differ between groups
(Fig. 2A). At 20 min of reperfusion tissue ATP content was
increased in the STH-POL compared to the STH-2 group
(P < 0.05) (Fig. 2B). Tissue levels of ADP increased from Baseline
to 58 min after cardiac arrest in both groups (P < 0.001) and
decreased to Baseline levels (P < 0.001) after 20 and 180 min of
reperfusion (Fig. 2C). AMP levels increased in both groups from
Baseline to 58 min of cardiac arrest (P < 0.01) and did not de-
crease after reperfusion (Fig. 2D). The level of hypoxanthine
increased significantly (P < 0.001) in the STH-POL group, and re-
mained increased at the same level at 20 min after declamping
(Fig. 2E). After 180 min hypoxanthine levels decreased to Baseline
levels (P < 0.001). Xanthine levels did not differ between groups
and did not change with time (Fig. 2F). There was an overall
change in energy charge (EC) over time (Pw = 0.025) with no
group differences (Table 3). However, multiple contrast tests
could not confirm differences between individual time points.
The ATP/ADP ratio (pooled means, n = 20) decreased from
Baseline to 58 min of cross-clamping (P < 0.001) and returned to
Baseline levels after 20 and 180 min of reperfusion. The CrP/ATP
ratio was unchanged.
Mitochondrial ultrastructure
Mitochondrial surface-to-volume ratio (SVratiomit) was slightly
decreased in the STH-POL compared to the STH-2 group at
20 min after reperfusion (6.74 ± 0.14 vs 7.46 ± 0.13 mm2/mm3;
P = 0.047) (Fig. 3A). None of these differences were present at
180 min of reperfusion. Neither mitochondrial surface density
(SVmit) nor the myocyte volume fractions of mitochondria, myo-
fibrils and cytosol differed between groups (Fig. 3B and Table 4).
For the fractional volumes the interobserver ICC varied between
0.741 and 0.897 with a CV% between 2.48% for myofibrils and
8.14% for sarcoplasma (Table 5). For mitochondrial surface to
volume ratio the interobserver ICC was 0.790 with a CV% of
4.05%. Based on ICC calculations, both the inter- and intra-
observer variabilities for morphometric data were classified as
good to excellent, except for the intra-observer ICC for volume
fraction of sarcoplasma [9].











A transient improvement in energy status with STH-POL cardio-
plegia was demonstrated as an increase in the myocardial tissue
content of CrP after 58 min of cardioplegic arrest and at 20 min
after reperfusion and weaning from CPB compared to STH-2 car-
dioplegia. Also, tissue ATP content was increased at 20 min after
reperfusion (Fig. 2A and B).
One of the components of the STH-POL cardioplegia is adeno-
sine, an endogenous purine nucleoside binding to the A1
receptor. Adenosine reduces cAMP by inhibiting adenylyl cyclase
and thereby acts as a KATP-channel opener. This causes outward
K+ flux and induces polarized cardiac arrest. The polarization ef-
fect is especially seen on myocardial conductive tissue such as
the atrioventricular node [10]. Esmolol is a cardio-selective beta1
adrenergic receptor blocker with rapid onset by blocking the fast
Na+ - and L-type Ca2+-channels initiating polarized arrest [11].
Clinically, esmolol seems to give protection from arrhythmias
and is protective in a vulnerable period [12]. In clinically relevant
animal studies esmolol as pre-treatment or as adjuvant to
Figure 1: Left ventricular haemodynamic variables, mean (SE) or median (25%; 75%), at Baseline and after CPB and 60 min of cardiac arrest with polarizing (STH-POL;
n = 10) and depolarizing (STH-2; n =10) cardioplegia. CI: cardiac index; LVSP and LVEDP: left ventricular peak systolic- and end-diastolic pressures; dP/dtmax and dP/
dtmin: peak positive and peak negative of the first derivative of left ventricular pressure; RM-ANOVA: analysis of variance for repeated measurements; Pw, Pg and
Pi: P-values for within subjects, between groups and interaction from two-way RM-ANOVA, respectively; #: significantly different from STH-2 at corresponding time
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potassium-based oxygenated blood cardioplegia improves left
ventricular contractility after weaning from CPB [13, 14]. Both ad-
enosine (T1=230 s) and esmolol (T1=29 min) have short half-lives
and the elimination does not depend on hepatic or kidney
function [15]. These two arresting agents act synergistically, re-
sulting in the desired effect at relatively low but effective concen-
trations, while minimizing potential adverse effects. Magnesium,
included in comparable concentrations both in the STH-POL and
Table 1: Baseline variables before cardiac arrest with polarizing (STH-POL) and depolarizing (STH-2) cardioplegia
Variable STH-POL STH-2 Statistics
HR (beats/min) 100 ± 6 91 ± 3 P = 0.23
LV-SPmax (mmHg) 92 ± 4 98 ± 3 P = 0.31
LV-EDP (mmHg) 7.1 ± 1.1 7.8 ± 0.7 P = 0.62
LV-dP/dtmax (mmHg/s) 1304 (1066; 1611) 1133 (1084; 1645) P = 0.85
LV-dP/dtmin (mmHg/s) -1638 (-1864; -1568) -1763 (-1871; -1732) P = 0.12
CI (L/min per m2) 3.8 ± 0.1 3.7 ± 0.2 P = 0.85
s (ms) 31.4 ± 1.1 31.9 ± 1.2 P = 0.76
RV-EDVi (ml/m
2) 132 ± 5 132 ± 5 P = 0.97
RV-EF (%) 32 ± 2 34 ± 2 P = 0.44
MAP (mmHg) 79 ± 4 88 ± 3 P = 0.092
CVPmean (mmHg) 7.3 ± 0.7 6.7 ± 0.7 P = 0.51
PAPmean (mmHg) 17.8 ± 0.9 17.2 ± 0.8 P = 0.61
Arterial blood gases
pH 7.50 ± 0.01 7.50 ± 0.01 P = 0.94
pCO2 (kPa) 5.42 ± 0.08 5.28 ± 0.08 P = 0.23
HCO3 - (mmol/l) 31.1 ± 0.5 30.1 ± 0.3 P = 0.10
BE (mmol/l) 7.3 ± 0.5 6.4 ± 0.3 P = 0.15
pO2 (kPa) 27.0 ± 0.3 27.4 ± 0.3 P = 0.41
Hb (g/dl) 7.7 ± 0.2 8.2 ± 0.5 P = 0.41
s-Na+ (mmol/l) 140 ± 1 141 ± 1 P = 0.22
s-K+ (mmol/l) 3.5 ± 0.1 3.6 ± 0.1 P = 0.74
s-Cl- (mmol/l) 102 (102; 103) 103 (101; 103) P = 0.76
Values are mean ± SEM or median (25-percentile; 75-percentile), n = 10.
LV and RV: left and right ventricle; HR: heart rate; SPmax and EDP: peak systolic and end-diastolic pressure; dP/dtmax and dP/dtmin: peak positive and peak nega-
tive of the first derivative of left ventricular pressure; CI: cardiac index; EF: ejection fraction; EDVi: end-diastolic volume indexed for body surface area; MAP:
mean arterial pressure; CVPmean: mean central venous pressure; PAPmean: mean pulmonary artery pressure; P: P-values from two-sample t-tests or Mann–
Whitney Rank Sum Tests.
Table 2: Cardiac and haemodynamic variables 60, 120 and 180 min after aortic declamping following 60 min of polarizing (STH-
POL) or depolarizing (STH-2) cardioplegic arrest
Variable 60 min 120 min 180 min RM-ANOVA statistics
RV-EDVi (ml/m
2)
STH-POL 116 ± 5 110 ± 4 105 ± 7 Pw = 0.24, Pg = 0.082, Pi = 0.83
STH-2* 128 ± 5 123 ± 7 121 ± 11
RV-SVi (ml/m
2)
STH-POL 37 ± 2 32 ± 2 34 ± 1 Pw < 0.001, Pg = 0.46, Pi = 0.10
STH-2* 41 ± 2 35 ± 2 32 ± 2
RV-EF (%)
STH-POL 32 ± 2 29 ± 2 34 ± 2 Pw = 0.12, Pg = 0.32, Pi = 0.085
STH-2* 33 ± 2 29 ± 2 27 ± 2
MAP (mmHg)
STH-POL 67 ± 5 69 ± 8 63 ± 5 Pw = 0.49, Pg = 0.34, Pi = 0.42
STH-2 76 ± 3 69 ± 3 71 ± 4
CVPmean (mmHg)
STH-POL 9.1 ± 0.6 9.8 ± 0.9 10.0 ± 0.8 Pw = 0.030, Pg = 0.52, Pi = 0.56
STH-2 8.4 ± 0.8 8.6 ± 1.1 9.7 ± 1.0
PAPmean (mmHg)
STH-POL 25 ± 2 26 ± 2 25 ± 2 Pw = 0.25, Pg = 0.50, Pi = 0.74
STH-2 23 ± 2 25 ± 2 24 ± 2
Values are mean ± SEM for 10 animals in each group (*n = 9).
RV: right ventricle; i: value indexed for body surface area; EDV: end-diastolic volume; SV: stroke volume; EF: ejection fraction; MAP: mean arterial pressure;
CVPmean: mean central venous pressure; PAPmean: mean pulmonary artery pressure. Pw, Pg and Pi: P-values for within subjects, between groups and interaction
from two-way RM-ANOVA, respectively.
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the STH-2 cardioplegia used in the present study supresses intra-
cellular Ca2+ overload during cardioplegia [16].
Mitochondrial creatine kinase present in the mitochondrial
intermembrane space regenerates CrP from creatine imported
from the cytosol and mitochondrial ADP. In the cytosol CrP
serves as an energy reservoir for the rapid buffering and regener-
ation of ATP in situ, as well as for intracellular energy transport
by the phosphocreatine shuttle or circuit [17, 18]. Our finding in-
dicates a decrease in consumption of CrP during the 60 min of
cardioplegic arrest and early reperfusion in the STH-POL group
(Fig. 2A). When reperfusion and contraction is re-established, the
differences between groups fade with time.
Since contraction is ceased during cardioplegic arrest in both
groups, the difference in CrP consumption is probably related to
reduced energy consumption with polarizing cardioplegia for
maintaining intracellular ion balance. For STH-2 cardioplegia
intracellular Na+ and Ca2+ overload occurs as a result of extracel-
lular hyperkalaemia. The energy dependent ion channel pumps
in the cellular membrane, Na+/K+-ATPase, Ca2+ channels and the
sarcoplasmic Ca2+ channel are active in correcting the imbalance
Figure 2: Myocardial tissue levels of creatine phosphate, high energy phosphates and degradation products at Baseline, after 58 min of cardiac arrest with polarizing
(STH-POL) and depolarizing (STH-2) cardioplegia, and 20 and 180 min after aortic declamping and reperfusion, n = 10 in both groups. CrP: creatine phosphate; ATP,
ADP and AMP: adenosine tri-, di- and monophosphate. Pw, Pg and Pi: P-values for within subjects, between groups and interaction from two-way RM-ANOVA, re-
spectively; *: significantly different from the previous value in the STH-POL group; #: significantly different compared to STH-2 at the corresponding time after
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in cytosolic ion composition. Since the Na+ and Ca2+ overload is
not prominent with polarizing cardiac arrest, these ion pumps
are less active during the phase of cardioplegic arrest. As a conse-
quence the requirement for CrP to rephosphorylate ADP to
maintain ATP levels is less pronounced (Fig. 2A). In addition, CrP
also stabilizes the membrane phospholipid bilayer by binding to
the polar heads and decreasing membrane fluidity. Stabilizing
the membrane attenuates some of the damage caused by transi-
ent ischaemia and hypoxia and helps to prevent cytoplasmic
leakage [1, 4, 17].
The consumption of ATP resulted in an increase in both tissue
ADP and AMP after 58 min of cardioplegic arrest in both groups.
The degradation product hypoxanthine is increased both during
arrest and at 20 min after declamping and reperfusion in the
STH-POL compared to the STH-2 group. The surplus myocardial
hypoxanthine in the STH-POL group is washed out with time
during reperfusion and not oxidized to xanthine due to minimal
levels of xanthine oxidase in the pig heart [19].
The decrease in surface-to-volume ratio of mitochondria at
20 min after reperfusion and declamping with STH-POL cardio-
plegia, indicates a temporary mitochondrial swelling (Fig. 3A).
Mitochondrial swelling can be observed as early as 10 min after
regional myocardial ischaemia [20]. Judged from the tissue levels
of HEP, there were no signs of a more severe ischaemia in the
STH-POL group than the STH-2 group. We speculate that this
could be a result of transient differences in intracellular ionic
composition and osmolality. Cytoplasmic volume fractions of cel-
lular components did not differ (Table 4).
Transient differences were observed for energy metabolism and
morphology at the end of the ischaemic period and at 20 min after
declamping and reperfusion. Cardiac index was increased in the
STH-POL compared to the STH-2 group from 150 min of reperfu-
sion and onwards (Fig. 1B). This improved function could be inter-
preted as a reduction of the ischaemia/reperfusion injury, reduced
myocardial stunning or alleviated adrenergic desensitization with
STH-POL compared to STH-2 cardioplegia. In the present study
myocardial injury was not evaluated. However, with a similar
protocol in a recent study showed that STH-POL cardioplegia did
not affect the release of troponin-T or myocardial caspase-3 activ-
ity as a sign of apoptosis [5]. Whether the transient differences in
energy metabolism indicate a reduction of reversible myocardial
Table 3: Energy status in myocardial tissue at Baseline, after 58 min of cardioplegic arrest with STH-POL or STH-2 cardioplegia; and
20 and 180 min after declamping and weaning from CPB
Baseline 58 min 20 min 180 min RM-ANOVA
Cross-clamp reperfusion reperfusion
Energy charge
STH-POL 0.89 ± 0.01 0.88 ± 0.01 0.90 ± 0.01 0.89 ± 0.01 Pw = 0.025, Pg = 0.75, Pi = 0.32
STH-2 0.90 ± 0.01 0.87 ± 0.01 0.88 ± 0.01 0.90 ± 0.01
ATP/ADP
STH-POL 5.10 ± 0.29 4.66 ± 0.25 5.25 ± 0.32 5.11 ± 0.30 Pw = 0.009, Pg = 0.84, Pi = 0.17
STH-2 5.73 ± 0.35 4.48 ± 0.37 4.82 ± 0.34 5.35 ± 0.27
CrP/ATP
STH-POL 1.57 ± 0.11 1.68 ± 0.16 1.69 ± 0.16 1.70 ± 0.15 Pw = 0.28, Pg = 0.36, Pi = 0.16
STH-2 1.65 ± 0.15 1.26 ± 0.20 1.48 ± 0.13 1.60 ± 0.12
Mean ± SEM, n = 10.
Energy charge (EC) calculated as: EC = (ATP + 0.5 ADP)/(AMP + ADP + ATP).
ATP and ADP: adenosine tri- and diphosphate; CrP: creatine phosphate. Pw, Pg and Pi: P-values for within subjects, between groups and interaction from two-
way RM-ANOVA, respectively.
Figure 3: Myocyte mitochondrial surface to volume ratio (Svratiomit) (A) and surface
density (SVmit) (B) in 10 animals in the STH-POL group and 9 animals in the STH-2
group. Bars are mean + SEM. Pw, Pg and Pi:P-values for within subjects, between
groups and interaction from two-way nested ANOVA, respectively; #: significantly
different from STH-2 at 20 min after declamping. One micrograph from each group
with morphometric readings close to mean values at 20 min after declamping.
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injury appearing as increased cardiac index after 150 min, cannot
be answered by this study.
Limitations
The study is performed in young pigs with healthy hearts. Both
the ischaemic time of 60 min and the 180 min of observation
after declamping and weaning from CPB are relatively short.
With regard to the development of myocardial stunning, the ob-
servation after weaning may have been extended. On the other
hand, the stability of the experimental protocol is also of import-
ance. The results in the present study could be directly compared
with a recent and similar study focusing on left ventricular func-
tion [5]. The serial tissue biopsies obtained demanded an infre-
quent need for a haemostatic myocardial suture. For this reason,
troponin-T was not evaluated in this study.
CONCLUSION AND IMPLICATIONS
These results demonstrate an improved energy status with polar-
izing oxygenated blood cardioplegia with esmolol/adenosine/
magnesium (STH-POL) compared to the standard potassium-
based depolarizing blood cardioplegia (STH-2) during 60 min of
cardioplegic arrest and at early reperfusion. Myocardial function
was improved from 150 min after reperfusion and onwards.
Comparable results should be obtained in clinical trials before
implementation into a new clinical routine.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
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